What the End of Part D Price Stabilization Means for 2027

Your own plan's 2027 notice shows what the end of Part D price stabilization means for you.

If your drug plan's 2027 letter arrived and the premium line made you stop and read it twice, you are not alone. Many people with a stand-alone Part D plan are hearing that a federal premium subsidy, the Part D Premium Stabilization Demonstration, ends after 2026. A fair first question is whether your plan took part, since the demonstration was voluntary and only participating plans received the extra federal help. The people who skip their Annual Notice of Change, the letter that lists next year's plan changes, are the ones who end up paying that difference without ever choosing to.

Plans are under real cost pressure. The final contract year 2027 rule, published in the Federal Register on April 6, 2026, records one commenter's warning that plans had higher-than-anticipated costs, partly from more people reaching the out-of-pocket cap. The same commenter noted there may be "additional pressure on bids in CY 2027" if current trends continue. Bids are what plans build their premiums from.

That premium also does not arrive alone. In 2026 the Part B deductible is $283, and a hospital stay under Part A carries a $1,736 deductible per benefit period. On a fixed income, small increases stack. I would rather you see your own numbers now than in January, so the place to begin is what Washington actually switched off this summer.

What exactly did CMS turn off for 2027, and what stays the same?

In short: What exactly did CMS turn off for 2027, and what stays the same?: CMS ends the Part D Premium Stabilization Demonstration at the end of 2026.

CMS ends the Part D Premium Stabilization Demonstration at the end of 2026. Your drug coverage continues, but stand-alone plans lose a federal premium cushion and a limit on yearly plan increases.

If you feel unsure whether this touches you, that is completely normal. It can help to answer three plain questions first:

1. Do you have Original Medicare plus a separate stand-alone drug plan? This change was built around that plan type.
2. Do you get your drug coverage inside a Medicare Advantage plan? The subsidy did not apply to those plans in the same way.
3. Have you seen a post saying Part D is ending? You can set that worry down, because the program continues.

On July 28, 2026, the Centers for Medicare & Medicaid Services said it would discontinue the demonstration at the end of CY 2026 and return Part D to "traditional market conditions" in 2027. A stand-alone prescription drug plan is the drug-only coverage many people pair with Original Medicare. CMS started the voluntary demonstration for those plans in 2025, after the Inflation Reduction Act (IRA) redesigned the drug benefit and stand-alone premiums began to swing and vary widely from plan to plan.

The agency's reason is brief. Its 2027 bid review indicated that plan sponsors now have "sufficient experience under the redesigned Part D benefit" to price their plans without extra federal help.

So what did the cushion actually do? In January 2025, the Congressional Research Service described a three-year program with a $15 direct subsidy applied to each participating plan's base premium, plus extra subsidies to hold yearly premium increases to $35. By 2026 the federal reduction had shrunk to $10, and a plan's premium could rise by as much as $50 over its 2025 level. Planned for three years, it is ending after two.

Contrary to the rumors that spread this summer, Part D itself is not going anywhere. What expires is a federal subsidy that helped offset monthly premiums. Coverage stays. Prices can move.

Two protections remain. The IRA's own premium stabilization rule, which is separate from the CMS demonstration, still caps growth in the base beneficiary premium at 6% per year through 2029. That base premium is the national starting figure CMS uses to calculate each plan's basic premium. The yearly out-of-pocket cap on covered drugs also stays in place.

A review of 3 sources for this section shows the same timeline: the subsidy began in 2025 and stops after 2026. In practice, the base premium still has a ceiling. That base premium still comes from the national average bid, which CMS publishes every year as its benchmark.

If you would rather sort this out from your kitchen table, you can. Understood Care is available in all 50 states, delivered virtually and covered by Medicare, which is one reason a Medicare advocate near you may not need to be local. Understood Care is also HIPAA-compliant, so you can share your plan letter and drug list knowing your health information stays safe and private, and that letter's premium line is where the next section picks up.

How much will stand-alone Part D premiums rise in 2027, and why might yours rise more?

Nationally, very little: the average stand-alone premium is projected to rise less than $1. Individual plans can rise much more, because nothing caps plan-level jumps in 2027.

The common assumption this year has been that losing a federal subsidy would set off a national price shock. The official projection says otherwise. AARP reported on September 29, 2026, that after the program paid $9.8 billion to stand-alone plans across 2025 and 2026, the average monthly stand-alone premium is still projected to move only from $35.09 in 2026 to $36 in 2027.

Here is how the national figures line up side by side.

The pressure underneath is real, even if it is easing. Ritter Insurance Marketing reports that the 2027 national average bid sits $56.78 above 2026, nearly a 24% increase, which is still the smallest year-over-year rise since the 2022 to 2023 plan years. That bid is a weighted average of what plans say basic coverage will cost, and as the firm's Roxanne Anderson puts it, it is "not the average Part D premium policyholders pay." Plans also wrote their 2027 bids before they knew the demonstration was ending.

Even a small dollar change is a large percentage jump on a premium near $36, as one prescription discount site points out. KFF's Juliette Cubanski told AARP that many enrollees "will see only modest premium increases" in their current stand-alone plan, "but others will see big jumps."

One enrollee shared their September notice in plain words: "Just got my notice of premium for 2027. Went from $101/month to $179/month." That is one person's plan, not a national trend. If your own notice shows a jump like that, keep it beside your 2026 paperwork, because Open Enrollment from October 15 lets you compare plans and switch.

You may also have seen a 40% figure going around. It came from a senator's August release describing how much the subsidies lowered average stand-alone premiums in 2025. It was never an official forecast for 2027.

If someone quotes you a single number this fall, it is fair to ask which year, which plans and whose estimate it is. When the premium on your notice is hard to find, the plan's member services line can confirm it. If I were reading a parent's notice this fall, I would set the national number aside and look only at the plan's own premium line, the same habit our guide to comparing Medicare plans without the hype encourages for advertised extras. If a doctor added a new drug for you this year, put it on your list before you compare plans.

What should you check in your 2027 Annual Notice of Change before December 7, and who can help?

Compare your 2027 premium, deductible, drugs, tiers and pharmacy against 2026. If something changed, an advocate actively working your case updates you every 7 days.

Many people set the Annual Notice of Change on the counter and plan to get to it later. That is a normal reaction to a thick envelope in a busy season. Still, your own plan's 2027 premium was not public until federal plan data came out in mid-to-late September 2026, so the notice may be the first time you see it. In August, Medicare writer Mariangel Martinez advised the agents who read her to put every stand-alone Part D client on Original Medicare on an October comparison list.

I think that advice fits families, too. Open the notice with your 2026 paperwork or a recent bill beside you, and go line by line:

1. The monthly premium. Write your 2026 amount next to the 2027 amount. Circle the difference in pen so a family member or advocate can see it at a glance.
2. The deductible. See whether the amount you pay before the plan starts sharing costs has changed.
3. Each of your drugs. Find every prescription on the 2027 drug list, called the formulary, and check that it stays on the same tier. A tier is the price level that sets your share.
4. Your pharmacy. Confirm the pharmacy you use is still in the plan's network for 2027.
5. New approval rules. Look for prior authorization, which means the plan wants to approve a drug before it pays for it.

Even insurers say the results are uneven. One insurer's own 2027 explainer says premium effects may vary by plan and location, with some members paying more and others seeing little change or even lower premiums. If your premium went down, the deductible and drug tiers still deserve the same check. For someone on several drugs, a tier change can matter more than the premium.

If your premium jumped, a Medicare Advantage plan may look like the easy way out. It can help to slow down first. Martinez also reported that Humana said on its earnings call it is exiting plans covering about 600,000 members for 2027, about 8% of its 7.2 million Medicare Advantage members. A lower premium helps less when the plan itself may not come back the next year.

You do not have to sort this out alone. At Understood Care, an advocate can go through your notice and drug list with you, compare each line against 2026 and make the calls to the plan. You hear from your advocate by phone, text or email while your case is active. Our rating stands at 4.8 across 148 reviews. If you are still deciding what kind of help you want, our guide to the best Medicare patient advocate services for seniors covers what to ask before you choose.

Open Enrollment closes December 7. Every week the envelope stays sealed is one less week to compare.

Where do Part D premiums go after 2027, and what should you do this fall?

Expect stand-alone premiums to keep inching up and plan-to-plan gaps to widen into 2028. Reading your own notice before December 7 is how you avoid paying the increase by default.

Here is my forecast, plainly. With the subsidy gone and the base premium allowed to climb every year, I expect 2028 notices to look more like 2027's than 2026's: a calm national average with wide swings underneath. The out-of-pocket cap keeps rising too, reaching $2,400 in 2027 under the Inflation Reduction Act. People on costly drugs will feel that ceiling more than any average.

Two things would change my mind. Congress or CMS could restore a premium subsidy for stand-alone plans before 2028, or 2028 bids could speed up again instead of slowing. Either would show up in next fall's notices first.

KFF's Juliette Cubanski put the advice in one line: shop around and "look past the premium to assess other benefit changes." The evidence I have does not yet include side-by-side 2026 and 2027 notices from real households, so the size of your own change stays unknown until you open yours, ideally this week, with your drug list on the table beside it.